ATE327235T1 - 1,2,5,10-tetrahydropyridazino 4,5-böchinolin-1, 0-dione und ihre anwendung in der behandlung von schmerzen - Google Patents

1,2,5,10-tetrahydropyridazino 4,5-böchinolin-1, 0-dione und ihre anwendung in der behandlung von schmerzen

Info

Publication number
ATE327235T1
ATE327235T1 AT01972860T AT01972860T ATE327235T1 AT E327235 T1 ATE327235 T1 AT E327235T1 AT 01972860 T AT01972860 T AT 01972860T AT 01972860 T AT01972860 T AT 01972860T AT E327235 T1 ATE327235 T1 AT E327235T1
Authority
AT
Austria
Prior art keywords
pain
treatment
böchinolin
tetrahydropyridazino
dione
Prior art date
Application number
AT01972860T
Other languages
English (en)
Inventor
Megan Murphy
Wenhua Xiao
Dean Gordon Brown
Rebecca Ann Urbanek
Frances Marie Mclaren
Edward Vacek
Thomas Bare
Carey Lynn Horchler
Christine Barlaam
Gary Banks Steelman
Vernon Alford
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE327235T1 publication Critical patent/ATE327235T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT01972860T 2000-09-29 2001-09-28 1,2,5,10-tetrahydropyridazino 4,5-böchinolin-1, 0-dione und ihre anwendung in der behandlung von schmerzen ATE327235T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23662900P 2000-09-29 2000-09-29

Publications (1)

Publication Number Publication Date
ATE327235T1 true ATE327235T1 (de) 2006-06-15

Family

ID=22890304

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01972860T ATE327235T1 (de) 2000-09-29 2001-09-28 1,2,5,10-tetrahydropyridazino 4,5-böchinolin-1, 0-dione und ihre anwendung in der behandlung von schmerzen

Country Status (8)

Country Link
US (1) US6833368B2 (de)
EP (1) EP1325002B1 (de)
JP (1) JP2004509962A (de)
AT (1) ATE327235T1 (de)
AU (1) AU2001292498A1 (de)
DE (1) DE60119949T2 (de)
ES (1) ES2263661T3 (de)
WO (1) WO2002026738A1 (de)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL111266A (en) * 1993-10-22 2002-03-10 Zeneca Ltd 2-HETEROARYL OR 2-ARYLPYRIDAZINO [4,5-b] QUINOLINE - 1, 10 - DIONES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
GB9507318D0 (en) * 1995-04-07 1995-05-31 Zeneca Ltd Alpha substituted pyridazino quinoline compounds
EP1248621A1 (de) * 1999-12-23 2002-10-16 AstraZeneca AB Verfahren und zusammensetzung zur behandlung von schmerzen
US20030181449A1 (en) * 1999-12-23 2003-09-25 Urbanek Rebecca Ann Methods and compositions for the treatment of pain
AU2566201A (en) * 1999-12-23 2001-07-09 Astrazeneca Ab Compounds and methods for the treatment of pain
DE60013326T2 (de) * 1999-12-23 2005-09-08 Astrazeneca Ab Verbindungen und verfahren zur behandlung von schmerz
EP1244453A1 (de) * 1999-12-23 2002-10-02 AstraZeneca AB Verfahren und zusammensetzung zur behandlung von schmerzen
JP4197216B2 (ja) 1999-12-24 2008-12-17 Ｊｓｒ株式会社 液状硬化性樹脂組成物およびその硬化物

Also Published As

Publication number Publication date
EP1325002A1 (de) 2003-07-09
EP1325002B1 (de) 2006-05-24
AU2001292498A1 (en) 2002-04-08
US20040058927A1 (en) 2004-03-25
DE60119949T2 (de) 2007-04-26
DE60119949D1 (de) 2006-06-29
ES2263661T3 (es) 2006-12-16
US6833368B2 (en) 2004-12-21
WO2002026738A1 (en) 2002-04-04
JP2004509962A (ja) 2004-04-02

Similar Documents

Publication Publication Date Title
YU69902A (sh) Novi derivati piperazina
ATE299890T1 (de) Inhibitoren von gamma-secretase
ATE401314T1 (de) Benzodiazepin-derivate als gamma-secretase inhibitoren
ATE269846T1 (de) N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
SE9504661D0 (sv) New compounds
DE60117605D1 (de) Thiazolyl-inhibitoren von tyrosinkinasen der tec-familie
NO972538D0 (no) Nye sulfonamider
DE60045508D1 (de) Dalda-analoge und ihre verwendung
FR2826270B1 (fr) Lingette et ses utilisations dans le domaine cosmetique
BG100069A (bg) Амидинови производни,съдържащи хетероциклични групи,получаване и приложението им
AU1182702A (en) Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same
PT992509E (pt) Novos derivados macrolidos
DK0782567T3 (da) Isothiourinstofderivater og fremgangsmåder til deres fremstilling
YU30603A (sh) Derivati premošćenog piperazina
TR200201128T2 (tr) PDE4 inhibitörleri olarak tetrahidrotiyopiranfitalazinon türevleri.
DE60121804D1 (de) Pharmazeutische zusammensetzung eines biguanin (metformin) und arginin
AU2001290480A1 (en) Cyclized benzamide neurokinin antagonists for use in therapy
ATE242220T1 (de) Benzimidazolderivate mit dopaminerger wirkung
DK1242410T3 (da) Nye forbindelser
DE60026883D1 (de) Methoden und zusammensetzungen zur behandlung von schmerzen
SE9903290D0 (sv) Novel compounds
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
MXPA02004441A (es) Derivados de isoxazol como inhibidores de la fosfodiesterasa.
ATE274513T1 (de) Verbindungen und verfahren zur behandlung von schmerz
SE9504662D0 (sv) New compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties